DNA damage induced by novel demethylcantharidin-integrated platinum anticancer complexes
Authors:
- Siu-Kwong PangSPSiu-Kwong Pang
- Chun-Wing YuCYChun-Wing Yu
- Steve C.F. Au-YeungSASteve C.F. Au-Yeung
- Yee-Ping HoYHYee-Ping Ho
- 1 November 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 363 (1) , 235-240
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexaneBioorganic & Medicinal Chemistry Letters, 2006
- Modifications of DNA by platinum complexesDrug Resistance Updates, 2005
- In vitro Assessment of Renal Toxicity and Inflammatory Events of Two Protein Phosphatase Inhibitors Cantharidin and Nor‐Cantharidin*Basic & Clinical Pharmacology & Toxicology, 2005
- Mismatch repair and DNA damage signallingDNA Repair, 2004
- Serine−Threonine Protein Phosphatase Inhibitors: Development of Potential Therapeutic StrategiesJournal of Medicinal Chemistry, 2002
- Effects of Spectator Ligands on the Specific Recognition of Intrastrand Platinum-DNA Cross-links by High Mobility Group Box and TATA-binding ProteinsJournal of Biological Chemistry, 2001
- Current Status of Platinum-Based Antitumor DrugsChemical Reviews, 1999
- DNA Cross-Linking Agents as Antitumor DrugsChemical Reviews, 1998
- Sequence- and Region-Specificity of Oxaliplatin Adducts in Naked and Cellular DNAMolecular Pharmacology, 1998
- Formation of DNA Adducts by the Anticancer Drug Carboplatin: Different Nucleotide Sequence Preferences in Vitro and in CellsBiochemistry, 1995